Fortress Biotech Reports Record Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Highlights

    NEXT STORY
    ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2019
    PREV STORY
    GENESIS HEALTHCARE REPORTS SOLID FOURTH QUARTER AND YEAR END 2019 RESULTS
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novartis phase II data for new inhaled combination treatment (QVM149) demonstrates significant improvements over current standard-of-care inhaled treatment

    author_avatar
    NASDAQ Market News

    New long-term data confirm Roche’s Gazyva/Gazyvaro extends the lives of people with chronic lymphocytic leukaemia compared to MabThera/Rituxan

    After a follow-up time of nearly five years the CLL11 study shows a 51% ...

    author_avatar
    NASDAQ Market News

    Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate and Active Vitamin D in Children with X-Linked Hypophosphatemia (XLH)

    Substantial Healing of Rickets Observed in 72% of Patients Treated with Crysvita Compared to ...

    author_avatar
    NASDAQ Market News